Fred Holubow
Plus aucun poste en cours
Profil
Fred E.
Holubow is the founder who founded V.P.
Pegasus Associates, Inc. in 1982.
He held the title of Vice President from 1982 to 2001.
Mr. Holubow's former jobs include Director positions at Savient Pharmaceuticals, Inc., Unimed Pharmaceuticals LLC, ThermoRetec Corp., and Micrus Endovascular LLC.
He also held the title of Portfolio Manager at William Harris Investors, Inc. Mr. Holubow's education history includes an undergraduate degree from Massachusetts Institute of Technology and an MBA from The University of Chicago.
Anciens postes connus de Fred Holubow
| Sociétés | Poste | Fin |
|---|---|---|
| TECOGEN INC. | Directeur/Membre du Conseil | 09/12/2023 |
| ANI PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2018 |
ANI Pharmaceuticals, Inc. /Old/
 ANI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come! | Directeur/Membre du Conseil | 18/07/2013 |
| V.P. Pegasus Associates, Inc. | Fondateur | 02/01/2001 |
Unimed Pharmaceuticals LLC
 Unimed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1999 and was headquartered in Marietta, GA. | Directeur/Membre du Conseil | - |
Formation de Fred Holubow
| Massachusetts Institute of Technology | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| TECOGEN INC. | Producer Manufacturing |
| Entreprise privées | 8 |
|---|---|
William Harris Investors, Inc.
 William Harris Investors, Inc. Investment ManagersFinance William Harris Investors, Inc. (WHI) is a privately-owned investment and wealth management firm headquartered in Chicago, Illinois. The firm serves as the family office for the Irving B. Harris family. Founded in 1976 by Irving B. Harris to manage his own family's capital, WHI has expanded its services and today provides a broad range of professional and wealth management services, including financial and estate planning, trust services, cash management, accounting and administrative services, tax preparation, and a variety of philanthropic services to four generations of the Harris family. | Finance |
Micrus Endovascular LLC
 Micrus Endovascular LLC Medical SpecialtiesHealth Technology Micrus Endovascular LLC operated as a medical device company. The company was founded in June 1996 and was headquartered in San Jose, CA. | Health Technology |
ThermoRetec Corp.
 ThermoRetec Corp. Environmental ServicesIndustrial Services ThermoRetec Corp. provides environmental services in the United states. The company was founded by Jeffrey L. Powell and is headquartered in Concord, MA. | Industrial Services |
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Gynex Pharmaceuticals, Inc.
 Gynex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Gynex Pharmaceuticals, Inc. is a pharmaceutical concern. The company is based in Vernon Hills, IL. Gynex Pharmaceuticals was acquired by Savient Pharmaceuticals, Inc. on August 09, 1993 for $47.87 million. | Health Technology |
Unimed Pharmaceuticals LLC
Unimed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Unimed Pharmaceuticals, Inc. manufactured pharmaceutical products. It provided multiple indications in the therapeutic areas of cardiology, men's health, HIV and other infectious diseases. The company was founded in 1999 and was headquartered in Marietta, GA. | Health Technology |
| V.P. Pegasus Associates, Inc. | Consumer Durables |
ANI Pharmaceuticals, Inc. /Old/
ANI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come! | Health Technology |